Biogen Inc. discovers, develops, manufactures, and delivers therapies in the United States, Europe, Germany, Asia, and internationally. The company provides TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, and TYSABRI for multiple sclerosis (MS); SPI...
Q2 2026
Jul 30, 2026
Q1 2026
Apr 29, 2026
FY 2025
Feb 6, 2026
Q4 2025
Q3 2025
Oct 30, 2025
